Physician profile
Thomas B Scully
NPI 1659366300
$13,327.67
in general payments reported to CMS, 2019-2025
24 companies · $6,473 in 2025
The $6,473 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,554 · 2020: $148 · 2021: $356 · 2022: $224 · 2023: $51.74 · 2024: $521 · 2025: $6,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $758 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $757.61 |
| Travel and Lodging | $288.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $6,558.56 | 2024-2025 | Tigershark M, Veo Lateral Interbody Fusion System, Triton |
| Surgalign Spine Technologies, INC. | $5,150.00 | 2019 | |
| Spineology INC. | $274.23 | 2019-2022 | |
| Nuvasive, INC. | $254.92 | 2019-2021 | |
| Medtronic, INC. | $233.97 | 2025 | Mazor X System, Concertotm, Hawkone |
| Pfizer INC. | $204.31 | 2019-2021 | |
| Providence Medical Technology, INC. | $114.80 | 2021-2025 | |
| Stryker Corporation | $59.16 | 2022-2025 | Artix Mt |
| Pacira Pharmaceuticals Incorporated | $58.24 | 2019-2020 | |
| Mimedx Group, INC. | $40.37 | 2024 | |
| Nevro Corp. | $39.70 | 2019-2021 | |
| Ethicon US, LLC | $38.51 | 2022 | |
| Cook Medical LLC | $34.21 | 2025 | Cook, Zenith Spiral-Z |
| Seaspine Orthopedics Corporation | $32.08 | 2019 | |
| Kerecis Limited | $30.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $30.23 | 2021 | |
| Orthofix Medical, INC. | $29.49 | 2022 | |
| Spine Wave, INC. | $28.58 | 2022 | |
| Cagent Vascular INC | $27.49 | 2025 | Serrantor |
| Abbott Laboratories | $23.83 | 2021 | |
| Integrity Implants INC. Dba Accelus | $20.78 | 2023 | |
| Intrinsic Therapeutics | $17.57 | 2025 | Barricaid Acd (Annular Closure Device) |
| Arbor Pharmaceuticals, INC. | $13.89 | 2019 | |
| Augmedics INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Scully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.